Evidence-based patient information in diabetes

Diabetic Medicine

Volumn 17, Issue 12, 2000, Pages 823-829

  Muhlhauser I ^a   Berger, M ^b  

^a UNIVERSITY OF HAMBURG   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

Decision making; Evidence based medicine; Health education; Risk communication; Type 2 diabetes mellitus; UKPDS

Indexed keywords

DIABETES MELLITUS; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL DECISION MAKING; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT INFORMATION; REVIEW; UNITED KINGDOM;

BLOOD PRESSURE; DIABETES MELLITUS; EVIDENCE-BASED MEDICINE; GREAT BRITAIN; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; PATIENT COMPLIANCE; PATIENT EDUCATION; PROSPECTIVE STUDIES;

EID: 0034521951     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-5491.2000.00383.x     Document Type: Review

References (30)

1. Diabetes education and insulin therapy: When will they ever learn
2. Diabetes care and patient oriented outcomes
3. Evidence based patient information
4. Evidence-based patient choice
5. Perils, pitfalls, and possibilities in talking about medical risk
6. Uncontrolled hypertension in Type 1 diabetes: Assessment of patients' desires about treatment and improvement of blood pressure control by a structured treatment and teaching programme
7. What role do patients wish to play in treatment decision making?
8. A patient decision aid regarding antithrombotic therapy for stroke prevention in atrial fibrillation
9. Sharing decisions with patients: Is the information good enough?
10. Absolutely relative: How research results are summarized can affect treatment decisions
11. The framing effect of relative and absolute risk
12. Influence of method of reporting study results on decision of physicians to prescribe drugs to lower cholesterol concentration
13. Communicating the benefits of chronic preventive therapy
14. Evidence based purchasing: Understanding results of clinical trials and systematic reviews
15. Implementing evidence based medicine in general practice: Audit and qualitative study of antithrombotic treatment for atrial fibrillation
16. Communicating the risk reduction achieved by cholesterol reducing drugs
17. Embracing patient partnership
18. Cancer risk communication: What we need to learn and what we know
19. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
20. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38
21. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
22. Langzeittherapie mit Sexualhormonen zur Krankheitsverhütung und Lebensverlängerung in der Postmenopause
23. UKPDS - Darstellung nach Evidence-based Medicine Kriterien
24. National electronic library for health (NeLH)
25. Rating health information on the Internet navigating to knowledge or to Babel?
26. Towards quality management of medical information on the internet: Evaluation, labelling, and filtering of information
27. DISCERN: An instrument for judging the quality of written consumer health information on treatment choices